Fouad Namouni, President, R & D at Blueprint Medicines Corp (BPMC), sold 6,482 shares at $98.18 ($636K) on 2021-10-05, disclosed to the SEC on 2021-10-07.
Open-market sale of $636k BPMC by President, R & D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $98.18 | 3,241 | $318K | 50.0% |
| 2 | $98.18 | 3,241 | $318K | 50.0% |
| Total | $98.18 avg | 6,482 | $636K | 100% |
| Filing → |
| BPMC | SELL | 2024-03-11 | $794K | — | Filing → |
| BPMC | SELL | 2023-10-05 | $362K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $175K | — | Filing → |